Product category:
Nucleic acid sequencing and synthesis
News Release from: Bio-Rad Laboratories | Subject: Bulletin 5540
Edited by the Laboratorytalk Editorial
Team on 05 December 2007
Technical note covers ranking and
epitope mapping
The study described in the technical note demonstrates the rapid, precise screening, and ranking of 20 hybridoma supernatants using Bio-Rad's Proteon XPR36 protein interaction array system
Bio-Rad's latest technical note, bulletin 5540, describes the screening, ranking, and epitope mapping of anti-human IL-9 supernatants Five high-affinity antibodies are identified, and four of these were selected for further purification and epitope mapping
This article was originally published on Laboratorytalk on 19 Feb 2002 at 8.00am (UK)
Related stories
Fully automated BSE testing system
New tests and automated platform promise to increase efficiency, produce faster results, expand mass screening capabilities, and reduce costs
New length for immobilized pH gradient strips
Bio-Rad Laboratories has added 18 cm IPG (immobilized pH gradient) strips to its popular ReadyStrip product line for the first dimension of 2-D gel electrophoresis
Two of the antibodies recognise different epitopes on the IL-9 antigen.
Both epitope mapping and hybridoma ranking were accomplished efficiently using Bio-Rad's One-shot kinetics approach and the parallel processing capability of the Proteon XPR36 system.
This work can be easily enhanced to include kinetic constant determination of hundreds of supernatants within only a few hours.
In the workflow used in this study, five supernatants were screened at a time against five antigen concentrations, and one channel was reserved for referencing.
Using this configuration, both the anti-mouse IgG and antibody-containing supernatants were injected into the same set of channels (ligand channels), followed by IL-9 injection into the orthogonal analyte channels.
Bio-rad's One-shot kinetics approach can be expanded to include all six available analyte channels and interspot referencing to conduct supernatant screening, yielding equally reliable results with greater throughput.
This is accomplished by using the ligand channel for immobilisation of anti-mouse IgG, the analyte channel for capture of the supernatant clones, and the ligand channels for IL-9 flow.
Contact Bio-Rad for a copy of bulletin 5540. Request a free brochure from Bio-Rad Laboratories ...
• Bio-Rad Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
